Innoviz Technologies
INVZ · NASDAQ
About INVZ
- Employees
- 372
- Headquarters
- Rosh Ha'Ayin, Central(HaMerkaz)
- Listed
- May 5, 2020
- Sector
- Information Technology
- Industry
- Electronic Equipment, Instruments & Components
- Website
- innoviz.tech
INVZ key statistics
- Market cap
- 66.72M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 2.85M
- Volume
- 2.06M
- Open price
- $0.2109
- High today
- $0.2316
- Low today
- $0.2109
- 52 Week high
- $2.11
- 52 Week low
- $0.21
Innoviz Technologies (INVZ) at a glance
Innoviz Technologies (INVZ) last traded at $0.2238, with a market cap of 66.72M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.2109 and $0.2316. The current price is 6.1% above the day's low and 3.4% below its high.
Volume so far is 2.06M shares, below the average of 2.85M shares a day.
Over the past year Innoviz Technologies has ranged from $0.21 to $2.11, and now sits 1% of the way up that range.
Innoviz Technologies met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.08 per share against an estimate of -$0.0816.
The average analyst price target is $0.408, 82.3% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy50.0%
- Hold50.0%
- Sell0.0%
- Low
- $0.404
- Now
- $0.2238
- High
- $0.42
INVZ earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 13.1% on average.
- Q3 FY24: reported -$0.15 per share against an estimate of -$0.1408
- Q4 FY24: reported -$0.11 per share against an estimate of -$0.1387
- Q1 FY25: reported -$0.07 per share against an estimate of -$0.0969
- Q2 FY25: reported -$0.09 per share against an estimate of -$0.0918
- Q3 FY25: reported -$0.08 per share against an estimate of -$0.0782
- Q4 FY25: reported -$0.10 per share against an estimate of -$0.0765
- Q1 FY26: reported -$0.12 per share against an estimate of -$0.0867
- Q2 FY26: reported -$0.08 per share against an estimate of -$0.0816
INVZ news
- Press releasePRNewswire
Innoviz Sets Third Quarter 2026 Conference Call for Wednesday, November 11 at 9:00 a.m. ET
- Press releasePRNewswire
Israel Defense Forces, Through the Ministry of Defense's Directorate of Defense, Research and Development (MAFAT) Recognizes Innoviz Technologies' LiDAR Capabilities as Suitable for Defense Applications
- Press releasePRNewswire
Innoviz Technologies Appoints Yoav Har-Even as Chairperson of the Board of Directors
- Press releasePRNewswire
Innoviz Reports Second Quarter 2026 Results
- Press releasePRNewswire
Innoviz Technologies to Develop LiDAR-Based Perception Stack for Highway Driving with Top 10 Global Automotive OEM
- Press releasePRNewswire
Innoviz Technologies Lands First Multi-Million Orders from Defense Customer
- Lekha Gupta
Why Is Innoviz Technologies Stock Falling Tuesday?
Similar companies
Companies in the same industry as Innoviz Technologies
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.